Beranda › Hipersensitivitas Kacang › Massachusetts › Boston
Uji klinis Hipersensitivitas Kacang di Boston, MA
6 studi untuk Hipersensitivitas Kacang mencari peserta di lokasi sekitar Boston (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Efficacy of Tezepelumab in Peanut Oral Immunotherapy
Menerima pesertaFase 2
- Massachusetts General Hospital: Department of Medicine: Allergy & Clinical Immunology Unit, Boston
- Boston Children's Hospital: Allergy and Asthma Program, Boston
Study of Oral Food Challenge Biomarkers (SAFER)
Menerima pesertaStudi observasional
- Boston Children's Hospital: Allergy and Asthma Program, Boston
Study to Evaluate the Safety, Pharmacokinetic, and Pharmacodynamic Effects of MY006 in Healthy Volunteers and Patients With Peanut Allergy
Menerima pesertaFase 1Sukarelawan sehat diterima
- Massachusetts General Hospital, Boston
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
Menerima pesertaFase 2
- Massachusetts General Hospital, Boston
- Boston's Children's Hospital, Boston
Evaluating the Safety and Efficacy of Oral Encapsulated Microbiota Transplantation Therapy in Peanut Allergic Patients
Menerima pesertaFase 2
- Boston Children's Hospital, Boston
VE416 for Treatment of Food Allergy
Menerima pesertaFase 1/2
- Massachusetts General Hospital, Boston
Uji klinis Hipersensitivitas Kacang di kota lain
- Little Rock, AR6 studi
- Ann Arbor, MI6 studi
- New York City, NY4 studi
- Durham, NC4 studi
- Cincinnati, OH3 studi
- Atlanta, GA3 studi
- Aurora, CO3 studi
Studi lain di Boston
- Kanker Payudara111 studi
- Kanker Paru Non-Sel Kecil90 studi
- Kanker (semua jenis)86 studi
- Kanker Kolorektal63 studi
- Kanker Metastatik63 studi
- Kanker Paru62 studi
- Kanker Ovarium61 studi
- Kanker Prostat59 studi
- Depresi52 studi
- Kanker Endometrium50 studi
- Gagal Jantung44 studi
- Leukemia Mieloid Akut44 studi
Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.